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Summary
 
We report that chlamydiae, which are obligate intracellular bacterial pathogens, possess a novel
antiapoptotic mechanism. Chlamydia-infected host cells are profoundly resistant to apoptosis
induced by a wide spectrum of proapoptotic stimuli including the kinase inhibitor staurospo-
rine, the DNA-damaging agent etoposide, and several immunological apoptosis-inducing mol-
ecules such as tumor necrosis factor-
 
a
 
, Fas antibody, and granzyme B/perforin. The antiapop-
totic activity was dependent on chlamydial but not host protein synthesis. These observations
suggest that chlamydia may encode factors that interrupt many different host cell apoptotic path-
ways. We found that activation of the downstream caspase 3 and cleavage of poly (ADP-ribose)
polymerase were inhibited in chlamydia-infected cells. Mitochondrial cytochrome c release
into the cytosol induced by proapoptotic factors was also prevented by chlamydial infection.
These observations suggest that chlamydial proteins may interrupt diverse apoptotic pathways
by blocking mitochondrial cytochrome c release, a central step proposed to convert the up-
stream private pathways into an effector apoptotic pathway for amplification of downstream
caspases. Thus, we have identified a chlamydial antiapoptosis mechanism(s) that will help define
chlamydial pathogenesis and may also provide information about the central mechanisms regu-
lating host cell apoptosis.
 
A
 
poptosis is an active process of cellular suicide trig-
gered by a variety of physiological and stress stimuli.
Besides having an important role in normal development
and tissue homeostasis, apoptosis has also been considered a
primary defense against viral infection (1–3). It has also
been demonstrated that apoptotic suicide by the infected
cells can limit the spread of intracellular bacterial infections
by provoking inflammatory responses (4) and/or by deliv-
ering the intracellular pathogens to competent professional
phagocytes (5). Furthermore, induction of target cell apop-
tosis constitutes an essential part of antigen-specific im-
mune effector mechanisms (6). It is therefore advantageous
for intracellular pathogens to develop strategies to inhibit
host cell apoptosis. In fact, many viral antiapoptotic genes
have been identified (7). These include viral inhibitors for
caspases such as CrmA in the cowpox virus (8) and p35 in
baculovirus (9), viral Bcl-2 homologues (10–12), viral prod-
ucts that can modulate p53 activity (13), viral homologues
of mammalian death receptors (14), and viral FLICE-inhib-
itory proteins (v-FLIPs) (15). Chlamydiae, which are obli-
gate intracellular bacterial pathogens, require several days of
intracellular replication and differentiation to produce suffi-
cient infectious progeny for spread to adjacent host cells (16).
Therefore, chlamydial organisms may also have evolved
strategies to counteract host cell apoptosis to productively
complete their obligate intracellular growth cycle.
Human chlamydial infections are recognized as the lead-
ing cause of many important sexually transmitted diseases
worldwide (17), and the development of chlamydial dis-
eases is largely due to persistent intracellular infection by
the organism. Chlamydiae have a unique intracellular bi-
phasic life cycle (16, 18). A typical chlamydial infection
starts with entry of an infectious elementary body (EB) into
host cells. Once internalized, an EB differentiates into a
noninfectious but metabolically active reticulate body (RB),
which multiplies and differentiates back to EBs. The ma-
ture EBs are then released extracellularly and spread to
other potential host cells. The entire intracellular growth
 
cycle in vitro takes 
 
z
 
48–72 h and occurs within a cytoplas-
 
1
 
Abbreviations used in this paper:
 
 EB, chlamydial infectious elementary
body; ECL, enhanced chemiluminescence; MOI, multiplicity of infec-
tion; PARP, poly(ADP-ribose) polymerase; PT, permeability transition;
RB, chlamydial noninfectious reticulate body.
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mic vacuole termed the chlamydial inclusion body. Since
RBs are structurally fragile and not infectious, it is essential
to maintain the integrity of host cells during chlamydial in-
tracellular growth not only for supply of nutrients but also
for shielding the intracellular organisms from host phagocy-
tosis (19) and antigen-specific immune effector mechanisms
(20). To achieve this, chlamydia may either sequester them-
selves to avoid activation of host cell apoptosis programs or
actively interrupt host apoptotic pathways. It is known that
infected host cells are able to respond to chlamydial attach-
ment and intracellular growth by increasing host cell pro-
tein phosphorylation (21) and cytokine secretion (22, 23).
Why, then, do the host cells often fail to activate a vital de-
fense mechanism, apoptosis, during intracellular chlamydial
infection? We proposed that intracellular chlamydial organ-
isms are able to actively inhibit infected host cells from
undergoing apoptosis. In the present study, we tested our
hypothesis by evaluating whether intracellular chlamydial
infection can inhibit host cell apoptosis induced by apop-
totic stimuli, and explored potential mechanisms of the
chlamydial antiapoptotic activity.
Apoptosis is a highly regulated cellular process that con-
sists of diverse upstream private pathways for transducing
extracellular death signals into intracellular events and a
common downstream effector pathway for amplification of
caspases. It has been demonstrated that different proapop-
totic factors deliver death signals to host cells by different
pathways (24–27) and mitochondrial cytochrome c release
may be a central step connecting the diverse upstream path-
ways to the common effector pathway for amplification of
downstream caspases (28–30). We found that chlamydia-
infected host cells were profoundly resistant to apoptosis
induced by both exogenous and immunological apoptosis-
inducing molecules. The antiapoptotic activity was further
correlated with the chlamydia-induced blockade of mito-
chondrial cytochrome c release and downstream caspase acti-
vation. Thus, chlamydial intracellular infection may interrupt
many different upstream apoptotic pathways by blocking
mitochondrial cytochrome c release.
 
Materials and Methods
 
Reagents, Cells, and Chlamydial Organisms.
 
Staurosporine, etopo-
side, penicillin G, chloramphenicol, and cycloheximide were from
Sigma Chemical Co. (St. Louis, MO). Rifampin was from Calbio-
chem Corp. (La Jolla, CA). The following cell lines were used in
this study: HeLa 229 (No. CCL-2.1; American Type Culture
Collection, Rockville, MD), U937 (No. CRL-1593; American
Type Culture Collection), and L929s (reference 31; provided by
Dr. S. Nagata, Osaka, Japan). All cells were cultured in either
RPMI (GIBCO BRL, Gaithersburg, MD) with 10% FCS (all
from Intergen Company, New York) or DMEM (GIBCO BRL)
with 10% FCS. The 
 
Chlamydia trachomatis
 
 serovar L2 (434/Bu),
serovar C (TW3/OT), and a mouse pneumonitis agent used in
this study were from Washington Research Foundation (Seattle,
WA). The organisms were grown in HeLa cells and purified as
described previously (32).
 
Chlamydia Infection.
 
Host cells were infected with chlamydial
organisms (serovar L2 or as specified) at a multiplicity of infection
(MOI) of 5 or as specified in individual experiments. For infec-
tion of adherent cells (HeLa and L929s), chlamydial organisms
were allowed to attach to monolayer cells grown either on glass
coverslips in 24-well plates (for microscopic observation) or in
tissue culture flasks (for Western blot assay and DNA fragmenta-
tion assay) for 2 h at 37
 
8
 
C. The chlamydial inocula were then re-
moved and DMEM medium with 10% FCS was added to the
monolayer cultures until the infected cells were used for apoptosis
induction. For infection of U937 cells, chlamydial organisms
were allowed to attach to the suspension cells at 4
 
8
 
C for 2 h at an
MOI of 20. We found that this high MOI was necessary to
achieve a high infection rate since U937 cells are less susceptible
to chlamydial infection (data not shown). After the chlamydial at-
tachment, the infected cells were then grown in DMEM with
10% FCS until they were subjected to apoptosis induction.
 
Apoptosis Induction.
 
Host cells with or without chlamydial in-
fection in 24-well plates or in tissue culture flasks were treated
with various apoptotic stimuli for various times in DMEM with
5% FCS as follows: HeLa cell samples were stimulated for 4 h
with 1 
 
m
 
M staurosporine, 5 h with 300 
 
m
 
M etoposide, or 2 
 
m
 
g/ml
granzyme B plus 0.12 
 
m
 
g/ml perforin purified as described previ-
ously (33). L929s cells were stimulated with mouse recombinant
TNF-
 
a
 
 (PharMingen, San Diego, CA) at 40 ng/ml for 8 h and
U937 cells were treated with either 40 ng/ml of human recombi-
nant TNF-
 
a
 
 (PharMingen) for 4 h or 250 ng/ml of mouse IgM
anti–human Fas antibody CH11 (Immunotech, Westbrook, ME)
for 8 h in the presence of 2 
 
m
 
g/ml of cycloheximide. The control
cells were treated with cycloheximide alone.
 
Apoptosis Assay.
 
At the end of the apoptosis induction, both
the stimulated and control cells were fixed with 4% paraformalde-
hyde in PBS for 30 min at room temperature followed by perme-
abilization with 0.5% saponin in PBS for 30 min at room temper-
ature. The cells were then stained with 10 
 
m
 
M of Hoechst 33258
(Sigma Chemical Co.) for 30 min at room temperature. After
washing three times with PBS, the stained cells were mounted
onto slides using FluorSave Reagent (Calbiochem, La Jolla, CA)
for evaluating apoptosis with a fluorescence microscope as de-
scribed previously (33). Cells from five random fields for each
sample were counted using a 
 
3
 
40 objective lens. The percent of
apoptotic cells was calculated as number of apoptotic cells/num-
ber of total cells counted.
 
Detection of Chlamydial Antigen, Cytochrome c, and Terminal
Transferase–Mediated dUTP nick-end labeling.
 
The various cell sam-
ples grown on glass coverslips in 24-well plates were subjected to
fixation and permeabilization as described above except that cell
samples for cytochrome c staining were permeabilized with
0.25% saponin. One set of coverslips was stained with the DNA
dye Hoechst only as described above. A second set of coverslips
was subjected to double staining to verify the presence of chro-
matin condensation and chlamydial antigens. The cell samples
were reacted with a mixture of terminal transferase (TdT) and bi-
otin-dUTP as described by the manufacturer (Boehringer Mann-
heim Canada, Laval, Canada). The biotin was visualized by react-
ing with avidin conjugated with FITC (Sigma Chemical Co.). The
same samples were costained with a rabbit antiserum against
chlamydial organisms (34) and probed with a goat anti–rabbit IgG
conjugated with Cy3 (Jackson ImmunoResearch Laboratories, West
Grove, PA). A third set of coverslips was stained for both chlamydial
antigens and host cytochrome c. A mouse mAb 6H2.B4 (IgG1;
PharMingen) specifically recognizing native cytochrome c was
reacted with the cell samples and the antibody reaction was visual-
ized with a goat anti–mouse IgG conjugated with Cy3 (Jackson Im-
munoResearch Laboratories). The chlamydial antigens were stained 
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with a rabbit antiserum followed by a goat anti–rabbit IgG conju-
gated with FITC (Sigma Chemical Co.). A fourth set of samples
was doubly stained with both the Hoechst dye and the anti–cyto-
chrome c antibody as described above. All samples with Hoechst
dye staining were viewed with a 
 
3
 
40 and photographed with a
 
3
 
100 objective lens using fluorescence microscopy as described
below. The cell samples doubly stained with dUTP plus anti-
chlamydia antiserum or with anti–cytochrome c antibody and an-
tichlamydia antiserum were analyzed by confocal microscopy as
described below.
 
Fluorescence and Confocal Microscopy.
 
Images from Hoechst
stained samples were acquired under a 
 
3
 
100 objective lens using
a Zeiss Axiophot microscope equipped with a cooled CCD cam-
era CH250/a (Photometrics Inc., Woburn, MA) with a KAF-
1400-50 sensor chip (1,317 
 
3
 
 1,035 pixels) driven by IPLabs
Spectrum H-SU2 (version 3.0; Signal Analytics Corp., Vienna,
VA) and Multiprobe 1.1 E (Signal Analytics Corp.) software on a
Power Macintosh 8100. The images were then copied into
Adobe photoshop files for printing. For confocal analysis, images
from the doubly stained samples were acquired using a confocal
fluorescence microscope equipped with an argon laser and dual
detectors (Molecular Dynamics, Sunnyvale, CA.). The images
were acquired with Image Space software using a 
 
3
 
60 objective
lens and then transferred into Adobe Photoshop for printing.
 
DNA Fragmentation (DNA Ladder) Assay.
 
HeLa cells with or
without infection and apoptosis induction were harvested by
trypsinization. After washing with PBS, 5 
 
3
 
 10
 
6
 
 cells from each
sample were lysed in a lysis buffer containing 5 mM EDTA, 5 mM
Tris, pH 8.0, and 0.5% Triton. The postnuclear supernatant was
extracted with phenol and chloroform before precipitation with
ethanol. The DNA solution was incubated at 37
 
8
 
C for 30 min in
the presence of RNase and electrophoresed in a 3% agarose gel.
Each lane was loaded with DNA sample from 1.5 
 
3
 
 10
 
6
 
 cells.
The gel was then stained with ethidium bromide.
 
Western Blot Analysis.
 
For Western blot analysis of caspase 3
and poly (ADP-ribose) polymerase (PARP), cells with or without
chlamydial infection or apoptosis induction were lysed with a
RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Tri-
ton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF,
1 
 
m
 
g/ml Aprotinin, 10 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml pepstatin A,
and 1 mM sodium orthovanadate) for 30 min on ice. After cen-
trifugation at 13,000 
 
g
 
 at 4
 
8
 
C for 15 min, the postnuclear super-
natants were loaded on a 15% polyacrylamide gel for caspase 3
and a 10% gel for PARP detection. Each lane was loaded with
the lysate from 3 
 
3
 
 10
 
5
 
 cells. After electrophoresis, the gels were
blotted onto nitrocellulose membrane (BioRad Lab., Hercules, CA),
which was then probed with either a mouse mAb to caspase 3
(clone No. 19; Transduction Laboratories, Lexington, KY) or a
mouse mAb to PARP (clone C2-10; PharMingen). Primary anti-
body binding was detected with a goat anti–mouse IgG-conjugated
with horseradish peroxidase (Jackson ImmunoResearch Labora-
tories) and visualized by enhanced chemiluminescence (ECL) as
described in the manufacturer’s instructions (Amersham Canada,
Oakville, Canada).
For analysis of cytochrome c, a procedure described elsewhere
was followed (29). Cell samples were collected by centrifugation
at 600 
 
g
 
 for 10 min at 4
 
8
 
C in a Beckman benchtop centrifuge.
The cell pellets were washed once with ice-cold PBS and resus-
pended with five volumes of buffer A (20 mM Hepes-KOH, pH
7.5, 10 mM KCl, 1.5 mM MgCl
 
2
 
, 1 mM sodium EDTA, 1 mM
sodium EGTA, 1 mM dithiothreitol, and 0.1 mM phenylmethyl-
sulfoyl fluoride) containing 250 mM sucrose on ice for 15 min.
The cells were homogenized with 15 to 20 strokes of a number
22 kontes douncer with the B pestle (Kontes Glass Company,
Vineland, NJ), and the homogenates were centrifuged twice at
750 
 
g
 
 for 10 min at 4
 
8
 
C. The supernatants were centrifuged at
10,000 
 
g
 
 for 15 min at 4
 
8
 
C, and the resulting pellets containing
mitochondria (designated as mitochondrial fraction) were resus-
pended in buffer A containing 250 mM sucrose and frozen in mul-
tiple aliquots at 
 
2
 
70
 
8
 
C. The supernatants were further cleared of
mitochondrial contamination by centrifugation at 100,000 
 
g
 
 for 1 h
at 4
 
8
 
C in an airfuge (Beckman, Fullerton, CA) and the resulting
supernatants (designated as cytosolic fraction) were also frozen in
aliqouts at 
 
2
 
70
 
8
 
C. 25 
 
m
 
g of protein from the cytosolic fraction
and 20 
 
m
 
g from the mitochondrial fraction for each sample were
loaded in each lane of a 15% polyacrylamide gel. Cytochrome c
was analyzed using the Western blot assay as described above ex-
cept that a mouse mAb 7H8.2C12 (IgG2b; PharMingen) specifi-
cally recognizing the denatured form of cytochrome c was used
to stain cytochrome c.
 
Results
 
Chlamydia-infected Cells Are Resistant to Apoptosis Induced
by a Wide Spectrum of Stimuli.
 
To evaluate whether intra-
cellular chlamydial infection can inhibit host cell apoptosis,
HeLa cells with or without chlamydial infection were first
treated with the kinase inhibitor staurosporine, a potent apop-
tosis inducer (30, 35). We found that staurosporine at 1 
 
m
 
M
efficiently induced 
 
.
 
90% of noninfected HeLa cells to be-
come apoptotic as revealed by both Hoechst staining of chro-
matin (Fig. 1 
 
A b
 
), the terminal transferase–mediated dUTP
nick-end labeling (TUNEL) assay (Fig. 1 
 
A g
 
) and the ap-
pearance of a DNA ladder (see Fig. 3). However, HeLa
cells infected with chlamydia were completely resistant to
staurosporine by these measures (Fig. 1 
 
A
 
, 
 
d
 
 and 
 
i
 
, and see
Fig. 3, 
 
bottom
 
). By evaluating samples with a low MOI for
chlamydial infection (Fig. 1 
 
A
 
, 
 
e
 
 and 
 
j
 
), we further ob-
served that the antiapoptotic activity was restricted to the
cells carrying the cytoplasmic chlamydial inclusion bodies.
Because cells harboring the inclusion bodies were the ones
that permitted chlamydial intracellular growth, this sug-
gested that intracellular chlamydial growth was required for
preventing the infected host cells from undergoing apopto-
sis induced by staurosporine. We also found antiapoptotic
activity in cells infected with other chlamydial strains such
as a 
 
C. trachomatis
 
 serovar C and a 
 
C. trachomatis
 
 mouse pneu-
monitis agent (data not shown), suggesting that the antiapop-
totic activity is a general property of the 
 
C. trachomatis
 
 spe-
cies. Since staining DNA with a Hoechst dye clearly
differentiated the apoptotic from normal nuclei and also si-
multaneously revealed the cytoplasmic chlamydial inclu-
sion bodies as demonstrated in Fig. 1 
 
A
 
 
 
c–e
 
, we used the
DNA staining assay to quantitate the apoptotic cells in the
following experiments.
We next asked whether chlamydia-infected cells were
also resistant to apoptosis induced by various immunologi-
cal killing molecules, as chlamydial antiapoptotic activity may
allow chlamydia to evade antigen-specific immune effector
mechanisms (20). Besides analysis of apoptosis induced by
the DNA-damaging agent etoposide and the kinase inhibi-
tor staurosporine, we evaluated the effect of chlamydial in- 
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fection on apoptosis initiated by three immunological killing
molecules including TNF-
 
a
 
, anti-Fas antibody, and gran-
zyme B/perforin. We found that chlamydial infection sig-
nificantly inhibited apoptosis induced by all five stimuli, al-
though the apoptosis induction potency of the different
agents varied (Fig. 1 
 
B
 
). Since these reagents are known to
use different “private” pathways to deliver death signals (24,
26, 27), this observation suggests that chlamydial intracellu-
lar infection may inhibit a common step that is required for
apoptosis induced by all of these reagents or block multiple
steps required by these proapoptotic reagents. To our know-
ledge, such a profound inhibition of apoptosis is unique
and led us to try to elucidate the mechanism(s).
 
Chlamydial Antiapoptotic Activity Is Dependent on Chlamyd-
ial, but Not Host, Protein Synthesis.
 
To understand the mecha-
nisms of chlamydia-induced antiapoptotic activity, we first
evaluated the kinetic relationship between the chlamydial
infection dose and antiapoptotic activity. Since staurospo-
rine is a strong apoptosis inducer and HeLa cells closely re-
semble the target cells of natural chlamydial infection, this
system was used in the following experiments. As shown in
Fig. 2 
 
A
 
, the time required for an infected cell to acquire
resistance to induced apoptosis was dependent on the in-
fection dose. HeLa cells infected at a higher MOI acquired
antiapoptotic activity sooner than those infected at a lower
MOI. For instance, at a MOI of 50, 
 
z
 
70% cells were resis-
tant to apoptosis induction 12 h after infection, whereas at
a MOI of 5, 
 
z
 
80% of the cells were susceptible to apopto-
sis induction at the same time point. Since infection at a
high MOI often accelerates chlamydial intracellular growth,
this observation suggests that active intracellular chlamydial
growth is required for the development of antiapoptotic
activity. In HeLa cultures infected with chlamydia at a
MOI of 0.5, on average only one organism entered a single
cell. We found that these cells became resistant after 24 h,
which is the time when the chlamydial vegetative RB mul-
tiplication reaches its peak. This observation suggests that
chlamydial antiapoptotic factors may be synthesized during
the replication stage.
To determine whether chlamydial protein synthesis is
required for the antiapoptotic activity, we evaluated the ef-
fect of several antibiotics. Fig. 2 
 
B
 
 shows that when the in-
fected HeLa cultures were treated with either rifampin to
block chlamydial transcription or chloramphenicol to block
chlamydial translation, the antiapoptotic activity was com-
pletely blocked, whereas staurosporine-induced cellular apop-
tosis was not affected. Rifampin and chloramphenicol are
known to suppress only prokaryotic and not eukaryotic pro-
tein synthesis at the concentration used in the experiment.
However, treatment with penicillin G did not significantly
alter the chlamydial antiapoptotic activity. Penicillin blocks
the chlamydial differentiation from the noninfectious RB
back to the infectious EB, but does not affect protein syn-
thesis (36). These observations demonstrate that chlamydial
protein synthesis is required for the chlamydial antiapop-
totic activity.
To address the question of whether the antiapoptotic ac-
tion also requires newly synthesized host proteins, we used
cycloheximide, an inhibitor of host cell but not chlamydial
protein synthesis. In the experiments shown in Fig. 2 
 
B
 
, cy-
cloheximide treatment did not suppress apoptosis induced
by staurosporine in uninfected HeLa cells and had no effect
on the chlamydial antiapoptotic activity. This observation sug-
gests that newly synthesized host proteins are not required for
the chlamydial antiapoptotic activity. Chlamydia-encoded an-
tiapoptotic factors may function by interacting with existing
cellular factors. We then tried to define which step(s) of cel-
lular apoptosis pathways is interrupted by chlamydial infection.
Figure 1. (A) Chlamydia-infected HeLa cells are resistant to apoptosis induced by staurosporine. HeLa cells with (c–e and h–j) or without (a, b, f, and g)
chlamydial infection at an MOI of 5 (1high, top, c, d, h, and i) or 0.5 (1low, e and j) were treated with (b, d, e, g, i, and j) or without (a, c, f, and h) 1 mM
staurosporine for 4 h. The cell samples were then either stained with Hoechst dye and viewed under a fluorescence microscope (a–e) or doubly labeled
with dUTP (green) and an antichlamydial antibody (red) and viewed under a confocal microscope (f–j) as described in Materials and Methods. Hoechst dye
stained both HeLa cell nuclei (black arrowhead, apoptotic nuclei) and the cytoplasmic chlamydial inclusion bodies (white arrowheads). (B) Chlamydia-infected
HeLa cells are resistant to apoptosis induced by multiple apoptotic stimuli. Host cells with (solid bars) or without (open bars) chlamydial infection were stim-
ulated with staurosporine (Stau), etoposide (ET), granzyme B/perforin (GB/P), an anti-Fas IgM antibody CH11 (aFas), or TNF-a. The cell samples were
then stained with Hoechst dye. Cells from five random fields were counted under an object lens of 340 and the percent of apoptotic cells were calculated
(displayed along the y-axis). The figure shows the results from three independent experiments. The variations between the three experiments were ,20%
as indicated by error bars.491 Fan et al.
Activation of Caspase 3 and PARP Hydrolysis Is Inhibited by
Chlamydial Intracellular Infection. Caspase 3 is one of the
key downstream members of the aspartate-specific cysteine
protease family that is thought to be an essential effector
of cell death (37). The targets of caspase 3 include DNA re-
pair proteins (38), and caspase 3 is activated in the late
stages of cellular apoptosis (39–41), so chlamydial antiapop-
totic factors may function by inhibiting its activation. As
shown in Fig. 3, p32 caspase 3 disappeared and was cleaved
to a p17 in HeLa cells treated with staurosporine, confirm-
ing that staurosporine-induced apoptosis activates caspase 3
(42). However, the processing of caspase 3 induced by
staurosporine in chlamydia-infected HeLa cells was com-
pletely inhibited. We evaluated the caspase enzymatic ac-
tivity by measuring the cleavage of the caspase 3 substrate
PARP. PARP p112 was reduced to the signature fragment
p86 in cells treated with staurosporine and again this was
blocked in chlamydia-infected cells. As a result of the inhi-
bition of caspase 3 activation, nucleosomal DNA fragmen-
tation was also suppressed in chlamydia-infected cells (Fig.
3, bottom). These observations suggest that the chlamydial
antiapoptotic factors may function by preventing the acti-
vation of caspase 3. However, it is not clear whether
chlamydial infection directly inhibits caspase 3 or blocks
upstream steps leading to its activation.
Mitochondrial Cytochrome c Release Is Blocked by Intracellular
Chlamydial Infection. It has been recently suggested that
mitochondria may play a central role in cellular apoptosis
(41–45) and the release of mitochondrial cytochrome c into
the cytosol may be required for activation of caspase 3 (29,
30, 41, 45, 46). We next tested whether chlamydial antiapop-
totic factors can prevent cytochrome c release. Confocal
microscopy was used initially to differentiate mitochondrial
from cytosolic cytochrome c staining in cells treated with
or without staurosporine (Fig. 4 A, a and b). We found that
normal HeLa cells displayed a punctate red staining pattern,
suggesting that cytochrome c in the normal HeLa cells is
mainly located in mitochondria as previously suggested (29,
30, 45). However, HeLa cells stimulated with staurosporine
lacked such granular staining and displayed a diffuse stain-
ing pattern, suggesting that the cytochrome c was released
into the cytosol upon staurosporine stimulation, as previ-
ously demonstrated by others (29, 30). When chlamydia-
infected cells were similarly stained, we found that cells
bearing an intracellular chlamydial inclusion body (Fig. 4
A, c–e; inclusion bodies, green) always displayed granular
staining regardless of staurosporine stimulation, suggesting
that intracellular chlamydial infection can indeed block mi-
tochondrial cytochrome c release into the cytosol. Inhibi-
tion of cytochrome c release was also found to be restricted
to the cells carrying the inclusion bodies (Fig. 4 A, e and j),
which is consistent with the observation that antiapoptotic
activity was restricted to the chlamydia-infected cells (Fig.
1 A, e and j). To further confirm that the cells with diffuse
cytochrome c staining were apoptotic, parallel cultures were
Figure 2. (A) Time course re-
lationship between chlamydial
infection dose and host cell apop-
tosis induced by staurosporine.
HeLa cells were infected with
chlamydial organisms with an
MOI of 0 (filled circles), 0.5 (open
squares), 5 (filled squares), or 50
(open circles). At various time
points after infection (0, 6, 12,
24, 36, or 48 h) as indicated along
the x-axis, the cells were stimu-
lated with 1 mM staurosporine for
4 h and stained with Hoechst dye
for evaluating the percentage of
apoptotic cells as described in the
Fig. 1 B legend. The figure shows
the result from one representa-
tive experiment of three independent experiments that were performed. (B) Effect of antibiotics and cycloheximide on chlamydial antiapoptotic activity.
HeLa cells infected with (hatched bars) or without (open bars) chlamydia in the presence of 1 mg/ml of rifampin, 60 mg/ml of chloramphenicol, or 100 mg/
ml penicillin G as indicated. Cycloheximide was added to the culture wells at a final concentration of 10 mg/ml 2 h before and during staurosporine stim-
ulation. After 1 mM staurosporine stimulation for 4 h, cell samples were analyzed for percentage of apoptotic cells as described in the Fig. 1 B legend. The
figure shows the result from three independent experiments. The variations between the three experiments were ,20% as indicated by error bars in the
figure.
Figure 3. Effect of chlamydial
infection on caspase 3 process-
ing, PARP cleavage, and DNA
fragmentation. HeLa cells with
(lanes  3 and 4) or without (lanes
1 and 2) chlamydial infection
and with (lanes 2 and 4) or with-
out (lanes 1 and 3) staurosporine
(1 mM) treatment were lysed for
Western blot analysis using anti-
bodies against caspase 3 (top) or
PARP (middle). The caspase 3
and PARP antibody staining was developed with a secondary antibody
conjugated to horseradish peroxidase followed by visualization using an
ECL as described in Materials and Methods. A 3% agarose gel was used
for the DNA ladder assay and ethidium bromide was used to visualize the
DNA bands (bottom).492 Chlamydial Inhibition of Apoptosis
costained with both anti–cytochrome c and the DNA stain-
ing dye Hoechst and viewed under a fluorescence micro-
scope. We found that cells with cytochrome c in mito-
chondria displayed normal nuclei (Fig. 4 A, f and h–j),
whereas the cells with cytosolic cytochrome c had apop-
totic nuclei (g and j). Thus, it is clear that only chlamydia-
infected cells displayed normal nuclei and mitochondrial
localization of cytochrome c upon staurosporine stimulation.
The blockade in mitochondrial cytochrome c release by
intracellular chlamydial infection was further confirmed bio-
chemically by Western blot (Fig. 4 B). In this experiment,
cell samples were separated into cytosolic and mitochon-
drial fractions as described in Materials and Methods. The
fractionated samples were then subjected to Western blot
analysis. By comparing the cytochrome c signal from mito-
chondrial fractions with that from cytosolic fractions, we
found that most of the cytochrome c was detected in the
mitochondrial fraction from normal HeLa cells, whereas in
staurosporine-treated cells the majority of the cytochrome
c was detected in the cytosolic fraction. This confirms the
finding using fluorescence staining of cytochrome c (Fig. 4 A)
and is consistent with previous reports of cytochrome c re-
lease during apoptosis (29, 30). In chlamydia-infected cells,
most of the cytochrome c was detected in the mitochon-
drial fractions even after staurosporine stimulation, which
suggests that mitochondrial cytochrome c release is blocked
by chlamydial infection.
We next tested whether the inhibition of immunological
apoptosis-inducing factors by chlamydia also prevents mito-
chondrial cytochrome c release. As shown in Fig. 4 C, we
found that both TNF-a and anti-Fas antibody treatment in the
presence of cycloheximide-induced mitochondrial cytochrome
c release (Fig. 4 C, a, b, d, and e) and chlamydial infection
significantly blocked the release. The chlamydial blockade of
mitochondrial cytochrome c release was correlated with
chlamydial inhibition of caspase 3 activation (Fig. 4 C, c and f).
Figure 4. (A) Immunofluores-
cence analysis of the effect of
chlamydial infection on cyto-
chrome c distribution. HeLa cells
were infected with chlamydial
organisms and treated with stau-
rosporine (1 mM) as described in
the Fig. 1 A legend. The cells
were then either stained for cy-
tochrome c (red) and chlamydial
antigens (green) and viewed un-
der a confocal microscope (a–e)
or stained for cytochrome c (red)
and DNA (blue; apoptotic nuclei,
white arrowheads; chlamydial in-
clusion bodies, white stars) with
Hoechst dye and viewed under a
fluorescence microscope (f–j).
Punctate red staining, mitochon-
drial localization; diffuse red stain-
ing, cytosolic localization. (B)
Western blot analysis of chlamyd-
ial inhibition of mitochondrial
cytochrome c release induced
by staurosporine. HeLa cells
were infected with chlamydial
organisms and treated with stau-
rosporine (1 mM) as described in
the Fig. 3 legend. The cell sam-
ples were then fractionated into
cytosol (lanes 1–4) and mito-
chondrial (5–8) fractions, and
analyzed by Western blot analy-
sis. A mouse mAb that specifi-
cally recognizes denatured cytochrome c was used to stain the blot and a secondary antibody conjugated with horseradish peroxidase was used to detect
the first antibody binding. The antibody reaction was visualized with ECL as described in Materials and Methods. The arrow denotes the position of cy-
tochrome c and the high molecular bands may represent proteins that cross-reacted with the anti–cytochrome c antibody. (C) Chlamydial infection sup-
presses mitochondrial cytochrome c release induced by TNF-a and anti-Fas antibody cross-linking. U937 cells were infected with chlamydial organism at an
MOI of 20. 30 h after infection, the cells were treated with either 40 ng/ml of human TNF-a for 4 h (a–c) or a mouse IgM antibody (CH11) against hu-
man Fas at 250 ng/ml for 8 h (d–f). Both treatments were carried out in the presence of 2 mg/ml of cycloheximide. The control cell samples were treated
with cycloheximide alone. The treated cell samples were then fractionated into cytosolic (b and e) and mitochondrial fractions (a and d) for Western blot
analysis as described in the Fig. 4 B legend. c was from the b blot; after stripping, the b blot was restained with an anti–caspase 3 antibody. f was similarly
restained after stripping e.493 Fan et al.
Discussion
We have demonstrated that chlamydia-infected host cells
are profoundly resistant to apoptosis induced by all apop-
totic stimuli tested. Although many viral antiapoptotic fac-
tors have been described (7, 47), there has been no previ-
ous reports of bacterial antiapoptotic activity, although it is
known that host cells are able to respond to intracellular
bacterial invasion with apoptosis (48, 49). These include
organisms such as Shigella flexneri (50), Listeria monocytogenes
(51), Mycobacterium tuberculosis (52), and Salmonella typhimu-
rium (53). Although the mechanisms of apoptosis induced
by bacterial intracellular invasion have not yet been eluci-
dated, in some cases the host apoptotic response can facili-
tate the killing of intracellular bacteria localized in cytoplasmic
vacuoles by either provoking an inflammatory response (4,
54) or by delivering the intracellular pathogens to compe-
tent professional phagocytes (5). Therefore, chlamydial an-
tiapoptotic activity may have evolved for suppressing the
host apoptotic response to the initial intracellular invasion.
As a result, the host cells can continuously supply nutrients
for chlamydial growth and the infected cells may shield the
intracellular organisms from host phagocytosis (19). Since
chlamydial infection also confers the infected cells with a
profound resistance to various apoptosis-inducing mole-
cules of immunological origin, the infection may protect
the intracellular pathogens from attack by host antigen-spe-
cific immune responses (20, 55). We have recently found
that cells infected with chlamydia are resistant to lysis by a
cytotoxic T lymphocyte hybridoma cell line (Hu, H., H.
Lu, and G. Zhong, manuscript in preparation). Thus sup-
pression of host cell primary defense (apoptotic responses)
and evasion of host antigen-specific immune attack as a re-
sult of the potent antiapoptotic may set the conditions for
persistent chlamydial infection.
The mechanism(s) by which chlamydial infection inhib-
its host cell apoptosis was further studied. Antiapoptotic ac-
tivity correlated well with chlamydia-induced blockade of
mitochondrial cytochrome c release and downstream cas-
pase activation. This suggests that chlamydial intracellular
infection interrupts many different upstream apoptotic path-
ways by blocking mitochondrial cytochrome c release. A
central role of mitochondria in converting various private
apoptotic pathways to a common effector pathway of final
amplification of caspase activation (43, 56) has recently been
proposed based on the following evidence. (a) Induction of
mitochondrial permeability transition (PT) can cause nu-
clear apoptosis, whereas prevention of PT can impede apop-
tosis in both a cell-free system and intact cells (57). (b)
Many proapoptotic factors including Fas are able to induce
mitochondrial PT and apoptosis-inducing factor release
(28, 58). (c) Mitochondrial cytochrome c release is neces-
sary for the cytosolic activation of caspase 3 and further nu-
clear apoptosis (30, 41, 46). (d) Many proapoptotic factors
including staurosporine (29), etoposide (45), actinomycin
D (45), cisplatinum (59) and Fas (60) stimulate mitochon-
drial cytochrome c release. (e) Overexpression of mitochon-
drial Bcl-2 or Bcl-xL blocks the mitochondrial PT change
(58), cytochrome c release (29, 45, 61, 62), and apoptosis
(44, 58, 62). The present study also provides additional
support for the model that suggests an essential role of mi-
tochondria in regulating apoptosis. We have demonstrated
that a wide spectrum of apoptotic reagents can induce both
mitochondrial cytochrome c release and apoptosis. Block-
ing of mitochondrial cytochrome c release by chlamydial
intracellular infection can prevent downstream caspase acti-
vation and nuclear apoptosis. Therefore it is clear that un-
derstanding the mechanisms of chlamydial antiapoptotic
activity will not only help define the basis of chlamydial
pathogenesis, but also provide new information on the cen-
tral mechanisms regulating host apoptosis.
We do not yet understand how chlamydial intracellular in-
fection blocks mitochondrial cytochrome c release. Chlamyd-
iae may preserve mitochondrial function and prevent mi-
tochondrial cytochrome c release by three potential
mechanisms. (a) Chlamydial infection may block the up-
stream steps that can perturb mitochondrial function. It has
been suggested that different proapoptotic and/or stress
factors may use different mechanisms to deliver signals to
mitochondria (24, 27, 43). To achieve a wide spectrum of
antiapoptosis activity, chlamydiae would have to produce
multiple antiapoptotic factors to deal with these many indi-
vidual mechanisms. This would be very inefficient, al-
though possible. (b) Chlamydial infection may upregulate
expression of mitochondrial Bcl-2 or Bcl-2–like molecules,
as these mitochondrial membrane proteins are able to pre-
vent cytochrome c release and caspase 3 activation. How-
ever, overexpression of Bcl-2 does not always protect from
apoptosis induced by Fas cross-linking (63–65). Furthermore,
overexpression of Bcl-XL failed to block apoptosis in U937
cells induced by TNF-a (26). We have examined Bcl-2 pro-
tein levels and they were not elevated in chlamydia-infected
cells (data not shown). It is therefore not likely that the
chlamydial antiapoptotic activity is solely mediated by host
Bcl-2 or Bcl-2–like molecules. However, we can not com-
pletely rule out the possibility that Bcl-2 or other mole-
cules of this family participate in chlamydial antiapoptotic
activity. (c) Chlamydia may produce novel antiapoptotic
factors. The chlamydial antiapoptotic activity requires chla-
mydial growth and is dependent on chlamydial, but not host
protein synthesis. Among the many viral antiapoptotic fac-
tors so far identified (7, 47), the ones with the broadest ef-
fects are the viral homologues of mammalian Bcl-2 such as
the BHRF1 protein from Epstein-Barr virus. BHRF1 can
inhibit apoptosis induced by both exogenous stimuli, in-
cluding DNA-damaging agents (66), the calcium ionophore
ionomycin (10), and immunological apoptosis-inducing
molecules such as TNF-a and Fas (67). These observations
suggest that a microbial homologue of apoptosis suppressors
such as Bcl-2 may be more potent than endogenous mam-
malian Bcl-2 in regulating apoptosis. We therefore hypoth-
esize that chlamydial organisms produce potent antiapop-
totic factors. Efforts to identify the potential chlamydial
antiapoptotic factor(s) are under way.494 Chlamydial Inhibition of Apoptosis
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